Susquehanna International Group’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Susquehanna International Group’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-45,200	Closed	-$1.58M	–	13637
2024 Q1	$1.58M	Buy	45,200 +33,100	+274%	+$1.21M	﹤0.01%	5884
2023 Q4	$460K	Buy	+12,100	New	+$259K	﹤0.01%	8879
2022 Q4	–	Sell	-18,400	Closed	-$330K	–	14739
2022 Q3	$330K	Buy	+18,400	New	+$332K	﹤0.01%	9549

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Susquehanna International Group's INBX Position: Q2 2024 in Review

Susquehanna International Group sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 63,710 shares — an estimated $2.23M sold.

Susquehanna International Group first reported a position in INBX in Q4 2021 and held it in 10 quarters. The position peaked at $4.04M in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

Susquehanna International Group reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Susquehanna International Group sold 63,710 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $2.23M.
Susquehanna International Group first reported a position in Inhibrx, Inc. Common Stock in Q4 2021 and held it in 10 quarters.
Susquehanna International Group's Inhibrx, Inc. Common Stock position peaked at $4.04M in Q4 2023.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.